Jill Sanchez - Mar 21, 2024 Form 4/A Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Financial Officer
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Jill Sanchez
Stock symbol
VCNX
Transactions as of
Mar 21, 2024
Transactions value $
$0
Form type
4/A
Date filed
5/14/2024, 04:35 PM
Date Of Original Report
Mar 22, 2024
Previous filing
Mar 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +805 $0.00 805 Mar 21, 2024 Common Stock 805 $8.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4.
F2 This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date.